AEON Biopharma, Inc. (AEON) is a publicly traded Healthcare sector company. As of May 21, 2026, AEON trades at $0.86 with a market cap of $22.49M and a P/E ratio of -0.22. AEON moved +0.91% today. Year to date, AEON is -23.64%; over the trailing twelve months it is +69.63%. Its 52-week range spans $0.38 to $115.57. Rallies surfaces AEON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AEON financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AEON recently traded at $0.86. Market cap is $22.49M. P/E ratio is -0.22. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $22.49M |
| P/E Ratio | -0.22 |
| EPS | $-3.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $115.57 |
| 52-Week Low | $0.38 |
| Volume | 553 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.22M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-39.22M | $-3.95 |
| 2024 | $0 | $42.01M | $77.74 |
| 2023 | $0 | $14.72M | $0.21 |
AEON analyst coverage data. Average price target: $0.00.